SHELBY ROBERTS: Open Payments
NPI 1922765635 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,153 in 145 payments from 25 companies in 2025. Trend: 2023 $1,936 · 2024 $2,402 · 2025 $3,153
Food & beverage: $3,076Education: $77
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 13 | $363 |
| ABBVIE INC. | 20 | $314 |
| PFIZER INC. | 17 | $286 |
| UCB, Inc. | 9 | $271 |
| ARGENX US, INC. | 13 | $242 |
| ACADIA Pharmaceuticals Inc | 8 | $189 |
| Teva Pharmaceuticals USA, Inc. | 6 | $177 |
| SK Life Science, Inc. | 7 | $168 |
| Lundbeck LLC | 6 | $143 |
| Janssen Biotech, Inc. | 3 | $139 |
Products named: EPIDIOLEX, NURTEC ODT, VYVGART, QULIPTA, LEQEMBI, NUPLAZID, Rystiggo, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
